Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection

NACompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

August 27, 2020

Primary Completion Date

March 7, 2022

Study Completion Date

March 7, 2022

Conditions
Covid19SARS-CoV-2
Interventions
OTHER

Sampling by venipuncture (and eventually by nasopharyngeal swab)

"Biological samples :~* Serum and plasma from each donor for the purpose of performing (if applicable) the SARS-CoV-2 serologic test~* PBMC (peripheral blood mononuclear cells)~* Nasopharyngeal samples (not mandatory)~Associated data :~* Demographic data~* Description of clinical manifestations related to SARS-CoV-2 infection~* Notion of hospitalization/ambulatory follow-up~Blood Fractioning~* Serum and plasma aliquoted and stored under 250, 500 and 1000 µL (at -80°C)~* Separation of PBMC on Lymphoprep and freezing in liquid nitrogen for subsequent analysis of immune system cells"

Trial Locations (1)

45000

Centre Hospitalier Régional d'Orléans, France, Orléans

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Institut Pasteur

INDUSTRY

lead

Centre Hospitalier Régional d'Orléans

OTHER